<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04647253</url>
  </required_header>
  <id_info>
    <org_study_id>S2358</org_study_id>
    <nct_id>NCT04647253</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)</brief_title>
  <acronym>AGENT IDE</acronym>
  <official_title>AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the AgentTM Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      AGENT IDE is a Prospective, Randomized (2:1), Multicenter Trial. The purpose of this study is&#xD;
      to assess the safety and effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter&#xD;
      compared to balloon angioplasty (POBA) in patients with in-stent restenosis (ISR) of a&#xD;
      previously treated lesion of up to 26 mm in length (by visual estimate) in a native coronary&#xD;
      artery 2.0 mm to 4.0 mm in diameter.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2021</start_date>
  <completion_date type="Anticipated">February 2028</completion_date>
  <primary_completion_date type="Anticipated">February 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, Randomized (2:1), Multicenter Trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Target Lesion Failure Rate</measure>
    <time_frame>12-month</time_frame>
    <description>The primary endpoint is the 12-month Target Lesion Failure (TLF) rate, defined as any ischemia-driven revascularization of the target lesion (TLR), myocardial infarction (MI, Q-wave and non-Q-wave) related to the target vessel, or cardiac death</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">480</enrollment>
  <condition>In-Stent Restenosis</condition>
  <arm_group>
    <arm_group_label>AGENT DCB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Agent DCB is a Monorail Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheter with a semi-compliant balloon coated with a formulation of paclitaxel (drug) and an excipient, Acetyl-Tri-n-butyl citrate (ATBC). The balloon catheter platform is based on the commercially available BSC Emerge™ PTCA balloon catheter system (K130391).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Commercially available, PTCA Dilation Catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AGENT DCB</intervention_name>
    <description>Drug coated PTCA balloon catheter</description>
    <arm_group_label>AGENT DCB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PTCA balloon catheter</intervention_name>
    <description>PTCA balloon catheter</description>
    <arm_group_label>Commercially available, PTCA Dilation Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Clinical Inclusion Criteria&#xD;
&#xD;
          -  Subject must be at least 18 years of age&#xD;
&#xD;
          -  Subject (or legal guardian) understands the trial requirements and the treatment&#xD;
             procedures, and provides written informed consent before any trial-specific tests or&#xD;
             procedures are performed&#xD;
&#xD;
          -  Subject is eligible for percutaneous coronary intervention (PCI)&#xD;
&#xD;
          -  Subject is willing to comply with all protocol-required follow-up evaluation&#xD;
&#xD;
          -  Women of child-bearing potential must agree to use a reliable method of contraception&#xD;
             from the time of screening through 12 months after the index procedure&#xD;
&#xD;
        Angiographic Inclusion Criteria (visual estimate)&#xD;
&#xD;
          -  In-stent restenosis in a lesion previously treated with either a drug-eluting stent or&#xD;
             bare metal stent, located in a native coronary artery with a visually estimated&#xD;
             reference vessel diameter (RVD) &gt; 2.0 mm and ≤ 4.0 mm.&#xD;
&#xD;
          -  Target lesion length must be &lt; 26 mm (by visual estimate) and must be covered by only&#xD;
             one balloon.&#xD;
&#xD;
          -  Target lesion must have visually estimated stenosis &gt; 50% and &lt; 100% in symptomatic&#xD;
             patients (&gt;70% and &lt;100% in asymptomatic patients) prior to lesion pre-dilation.&#xD;
&#xD;
          -  Target lesion must be successfully pre-dilated.&#xD;
&#xD;
             o Note: Successful predilation/pretreatment refers to dilation with a balloon catheter&#xD;
             of appropriate length and diameter, or pretreatment with directional or rotational&#xD;
             coronary atherectomy, laser or cutting/scoring balloon with no greater than 50%&#xD;
             residual stenosis and no dissection greater than National Heart, Lung, Blood Institute&#xD;
             (NHLBI) type C. Thrombolysis in Myocardial Infarction (TIMI) grade flow in the target&#xD;
             lesion must be &gt;2&#xD;
&#xD;
          -  If a non-target lesion is treated, it must be treated first and must be deemed a&#xD;
             success.&#xD;
&#xD;
               -  Note: Successful treatment of a non-target lesion is defined as a residual&#xD;
                  stenosis of ≤ 30% in 2 near-orthogonal projections with TIMI 3 flow, as visually&#xD;
                  assessed by the physician, without the occurrence of prolonged chest pain or ECG&#xD;
                  changes consistent with MI.&#xD;
&#xD;
        Clinical Exclusion Criteria&#xD;
&#xD;
          -  Subject has other serious medical illness (e.g. cancer, congestive heart failure) that&#xD;
             may reduce life expectancy to less than 24 months.&#xD;
&#xD;
          -  Subject has current problems with substance abuse (e.g. alcohol, cocaine, heroin,&#xD;
             etc.).&#xD;
&#xD;
          -  Subject has planned procedure that may cause non-compliance with the protocol or&#xD;
             confound data interpretation.&#xD;
&#xD;
          -  Subject is participating in another investigational drug or device clinical study that&#xD;
             has not reached its primary endpoint.&#xD;
&#xD;
          -  Subject intends to participate in another investigational drug or device clinical&#xD;
             study within 12 months after the index procedure.&#xD;
&#xD;
          -  Woman who is pregnant or nursing. (A pregnancy test must be performed within 7 days&#xD;
             prior to the index procedure, except for women who definitely do not have&#xD;
             child-bearing potential.)&#xD;
&#xD;
          -  Left ventricular ejection fraction known to be &lt; 25%.&#xD;
&#xD;
          -  Subject had PCI or other coronary interventions within the last 30 days.&#xD;
&#xD;
          -  Planned PCI or CABG after the index procedure.&#xD;
&#xD;
          -  STEMI or QWMI &lt;72h prior to the index procedure.&#xD;
&#xD;
          -  Cardiogenic shock (SBP &lt; 80 mmHg requiring inotropes, IABP or fluid support).&#xD;
&#xD;
          -  Known allergies against paclitaxel or other components of the used medical devices.&#xD;
&#xD;
          -  Known hypersensitivity or contraindication for contrast dye that in the opinion of the&#xD;
             investigator cannot be adequately pre-medicated.&#xD;
&#xD;
          -  Intolerance to antiplatelet drugs, anticoagulants required for procedure.&#xD;
&#xD;
          -  Platelet count &lt; 100k/mm3 (risk of bleeding) or &gt; 700k/mm3.&#xD;
&#xD;
          -  Subject with renal insufficiency (creatinine ≥2.0 mg/dl) or failure (dialysis&#xD;
             dependent).&#xD;
&#xD;
          -  Subject has suspected or proven COVID-19 at present or within the past 4 weeks with&#xD;
             resolution of symptoms.&#xD;
&#xD;
        Angiographic Exclusion Criteria (visual estimate)&#xD;
&#xD;
          -  Target lesion is located within a bifurcation with planned treatment of side branch&#xD;
             vessel.&#xD;
&#xD;
          -  Target lesion is located within a saphenous vein or arterial graft.&#xD;
&#xD;
          -  Thrombus present in the target vessel&#xD;
&#xD;
          -  &gt; 50% stenosis of an additional lesion proximal or clinically significant distal&#xD;
             (&gt;2.0mm RVD) to the target lesion.&#xD;
&#xD;
          -  Patient with unprotected left main coronary artery disease. (&gt;50% diameter stenosis)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Yeh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Maurer</last_name>
    <phone>800-876-9960</phone>
    <email>amy.maurer@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia O'Mara</last_name>
    <phone>800-876-9960</phone>
    <email>patricia.omara@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>San Francisco Veterans Affairs Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kendrick Shunk, MD</last_name>
      <email>kendrick.shunk@va.gov</email>
    </contact>
    <investigator>
      <last_name>Kendrick Shunk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Tremmel, MD</last_name>
      <email>jtremmel@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Jennifer Tremmel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Anthony Hospital</name>
      <address>
        <city>Lakewood</city>
        <state>Colorado</state>
        <zip>80216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Altman, MD</last_name>
      <email>jaltman@chvpc.com</email>
    </contact>
    <investigator>
      <last_name>John Altman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Denver Cardiology</name>
      <address>
        <city>Littleton</city>
        <state>Colorado</state>
        <zip>80210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cinthia Bateman</last_name>
      <email>cbateman@southdenver.com</email>
    </contact>
    <investigator>
      <last_name>Cinthia Bateman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tallahassee Memorial Hospital</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Dixon, MD</last_name>
      <email>widix@southern-med.com</email>
    </contact>
    <investigator>
      <last_name>William Dixon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Nicholson, MD</last_name>
      <email>wjnicho@emory.edu</email>
    </contact>
    <investigator>
      <last_name>William Nicholson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northside Hospital</name>
      <address>
        <city>Lawrenceville</city>
        <state>Georgia</state>
        <zip>30046</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Grines, MD</last_name>
      <email>cindy.grines@northside.com</email>
    </contact>
    <investigator>
      <last_name>Cindy Grines, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evanston Hospital</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Levisay, MD</last_name>
      <email>jlevisay@northshore.org</email>
    </contact>
    <investigator>
      <last_name>Justin Levisay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Overland Park Regional Medical Center</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Marso, MD</last_name>
      <email>steve.marso@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Steven Marso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajan Patel, MD</last_name>
      <email>rapatel@ochsner.org</email>
    </contact>
    <investigator>
      <last_name>Rajan Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carey Kimmelstiel, MD</last_name>
      <email>CKimmelstiel@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>Carey Kimmelstiel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farouc Jaffer, MD</last_name>
      <email>fjaffer@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Farouc Jaffer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Croce, MD</last_name>
      <email>kcroce@partners.org</email>
    </contact>
    <investigator>
      <last_name>Kevin Croce, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Yeh</last_name>
      <email>ryeh@bidmc.harvard.com</email>
    </contact>
    <investigator>
      <last_name>Robert Yeh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khaldoon Alaswad, MD</last_name>
      <email>kalaswa1@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Khaldoon Alaswad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Brechtken, MD</last_name>
      <email>johannes.x.brechtken@healthpartners.com</email>
    </contact>
    <investigator>
      <last_name>Johannes Brechtken, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital of Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. Aaron Grantham, MD</last_name>
      <email>jgrantham@cc-pc.com</email>
    </contact>
    <investigator>
      <last_name>J. Aaron Grantham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Moses</last_name>
      <email>jm2456@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Moses, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Azeem Latib, MD</last_name>
      <email>mlatib@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Azeem Latib, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Shlofmitz, MD</last_name>
      <email>richard.shlofmitz@chsli.org</email>
    </contact>
    <investigator>
      <last_name>Richard Shlofmitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lindner Center for Research and Education at Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Rudick, MD</last_name>
      <email>steven.rudick@thechristhospital.com</email>
    </contact>
    <investigator>
      <last_name>Steven Rudick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amar Krishnaswamy, MD</last_name>
      <email>krishna2@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Amar Krishnaswamy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Pinnacle Health</name>
      <address>
        <city>Wormleysburg</city>
        <state>Pennsylvania</state>
        <zip>17053</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Bachinsky</last_name>
      <email>bachinskywb@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>William Bachinsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinnette Abbott, MD</last_name>
      <email>jabbott@lifespan.org</email>
    </contact>
    <investigator>
      <last_name>Jinnette Abbott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist North Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claro Diaz, MD</last_name>
      <email>cdiaz@sutherlandclinic.com</email>
    </contact>
    <investigator>
      <last_name>Claro Diaz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centennial Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Jefferson</last_name>
      <email>Brian.Jefferson@HCAhealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Brian Jefferson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart Hospital of Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis Zidar, MD</last_name>
      <email>frank.zidar@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Francis Zidar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Heart and Vascular Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Stoler</last_name>
      <email>rcstoler@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Robert Stoler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alpesh Shah, MD</last_name>
      <email>arshah@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Alpesh Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia Medical Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Taylor, MD</last_name>
      <email>amt6b@virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Angela Taylor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Behnam Tehrani, MD</last_name>
      <email>behnam.tehrani@inova.org</email>
    </contact>
    <investigator>
      <last_name>Behnam Tehrani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 23, 2020</study_first_submitted>
  <study_first_submitted_qc>November 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2020</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Drug coated balloon</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

